These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 23807657)

  • 1. Antimicrobial treatment of febrile neutropenia: pharmacokinetic-pharmacodynamic considerations.
    Goulenok T; Fantin B
    Clin Pharmacokinet; 2013 Oct; 52(10):869-83. PubMed ID: 23807657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacodynamic and pharmacokinetic of antibiotics for treatment of skin and soft tissue infections].
    Mazzei T; Novelli A; Arrigucci S
    Infez Med; 2009 Sep; 17 Suppl 4():37-57. PubMed ID: 20428019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal dosing design for antibiotic therapy in the elderly: a pharmacokinetic and pharmacodynamic perspective.
    Noreddin AM; El-Khatib W; Haynes V
    Recent Pat Antiinfect Drug Discov; 2008 Jan; 3(1):45-52. PubMed ID: 18221185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can Pharmacokinetic and Pharmacodynamic Principles Be Applied to the Treatment of Multidrug-Resistant Acinetobacter?
    Cooper TW; Pass SE; Brouse SD; Hall RG
    Ann Pharmacother; 2011 Feb; 45(2):229-40. PubMed ID: 21304038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of pharmacokinetics/pharmacodynamics of antibacterials in their dosing regimen selection.
    Scaglione F; Paraboni L
    Expert Rev Anti Infect Ther; 2006 Jun; 4(3):479-90. PubMed ID: 16771624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the addition of aminoglycosides to beta-lactams in cancer patients with febrile neutropenia needed?
    Contreras V; Sepúlveda S; Heredia A
    Medwave; 2016 Feb; 16 Suppl 1():e6379. PubMed ID: 26938974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosing antibiotics in neonates: review of the pharmacokinetic data.
    Rivera-Chaparro ND; Cohen-Wolkowiez M; Greenberg RG
    Future Microbiol; 2017 Sep; 12(11):1001-1016. PubMed ID: 28758800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infusional β-lactam antibiotics in febrile neutropenia: has the time come?
    Abbott IJ; Roberts JA
    Curr Opin Infect Dis; 2012 Dec; 25(6):619-25. PubMed ID: 22964948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of extended infusion of β-lactam antibiotics for the treatment of febrile neutropenia in haematologic patients: protocol for a randomised, multicentre, open-label, superiority clinical trial (BEATLE).
    Laporte-Amargos J; Gudiol C; Arnan M; Puerta-Alcalde P; Carmona-Torre F; Huguet M; Albasanz-Puig A; Parody R; Garcia-Vidal C; Del Pozo JL; Batlle M; Tebé C; Rigo-Bonnin R; Muñoz C; Padullés A; Tubau F; Videla S; Sureda A; Carratalà J
    Trials; 2020 May; 21(1):412. PubMed ID: 32423462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic/pharmacodynamic target attainment of intravenous β-lactam regimens against Gram-negative bacteria isolated in a Brazilian teaching hospital.
    Furtado GH; Cardinal L; Macedo RS; Silva JO; Medeiros EA; Kuti JL; Nicolau DP
    Rev Soc Bras Med Trop; 2015; 48(5):539-45. PubMed ID: 26516962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal antibiotic dosing. The pharmacokinetic-pharmacodynamic interface.
    Reed MD
    Postgrad Med; 2000 Dec; 108(7 Suppl Contemporaty):17-24. PubMed ID: 19667545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended vs Bolus Infusion of Broad-Spectrum β-Lactams for Febrile Neutropenia: An Unblinded, Randomized Trial.
    Ram R; Halavy Y; Amit O; Paran Y; Katchman E; Yachini B; Kor S; Avivi I; Ben-Ami R
    Clin Infect Dis; 2018 Sep; 67(8):1153-1160. PubMed ID: 29608680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of infection models and PK/PD modelling for optimising care of critically ill patients with severe infections.
    Tängdén T; Ramos Martín V; Felton TW; Nielsen EI; Marchand S; Brüggemann RJ; Bulitta JB; Bassetti M; Theuretzbacher U; Tsuji BT; Wareham DW; Friberg LE; De Waele JJ; Tam VH; Roberts JA;
    Intensive Care Med; 2017 Jul; 43(7):1021-1032. PubMed ID: 28409203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Pharmacodynamics of Prolonged Infusion β-Lactams for the Treatment of Pseudomonas aeruginosa Infections: A Systematic Review.
    Thabit AK; Hobbs ALV; Guzman OE; Shea KM
    Clin Ther; 2019 Nov; 41(11):2397-2415.e8. PubMed ID: 31679822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic antimicrobial agents for postoperative infections: appropriate use of antibiotics from the viewpoint of pharmacokinetic/pharmacodynamic theory].
    Takesue Y; Nakajima K; Wada Y; Ichiki K; Yanagi H; Ikeuchi H
    Nihon Geka Gakkai Zasshi; 2006 Sep; 107(5):224-9. PubMed ID: 17017418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis.
    Roberts JA; Lipman J
    Clin Pharmacokinet; 2006; 45(8):755-73. PubMed ID: 16884316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimising dosing strategies of antibacterials utilising pharmacodynamic principles: impact on the development of resistance.
    DeRyke CA; Lee SY; Kuti JL; Nicolau DP
    Drugs; 2006; 66(1):1-14. PubMed ID: 16398565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents.
    Hyatt JM; McKinnon PS; Zimmer GS; Schentag JJ
    Clin Pharmacokinet; 1995 Feb; 28(2):143-60. PubMed ID: 7736689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of Cefepime in Patients with Cancer and Febrile Neutropenia in the Setting of Hematologic Malignancies or Hematopoeitic Cell Transplantation.
    Whited L; Grove M; Rose D; Rhodes NJ; Scheetz MH; O'Donnell JN; Neeb J; Thoele K; Jones DR; Lowe C; Moore D; Kiel PJ
    Pharmacotherapy; 2016 Sep; 36(9):1003-10. PubMed ID: 27496678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous-infusion beta-lactam antibiotics during continuous venovenous hemofiltration for the treatment of resistant gram-negative bacteria.
    Moriyama B; Henning SA; Neuhauser MM; Danner RL; Walsh TJ
    Ann Pharmacother; 2009 Jul; 43(7):1324-37. PubMed ID: 19584386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.